<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wulf M</submitter><funding>Ministry of Innovation, Science and Research of North-Rhine Westphalia, Germany</funding><funding>German Federal Ministry of Education and Research</funding><pagination>3538</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9688080</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(22)</volume><pubmed_abstract>Neuromelanin granules (NMGs) are organelle-like structures present in the human &lt;i>substantia nigra pars compacta&lt;/i>. In addition to neuromelanin, NMGs contain proteins, lipids and metals. As NMG-containing dopaminergic neurons are preferentially lost in Parkinson's disease and dementia with Lewy bodies (DLB), it is assumed that NMGs may play a role in neurodegenerative processes. Until now, this role is not completely understood and needs further investigation. We therefore set up an exploratory proteomic study to identify differences in the proteomic profile of NMGs from DLB patients (n = 5) compared to healthy controls (CTRL, n = 5). We applied a laser microdissection and mass-spectrometry-based approach, in which we used targeted mass spectrometric experiments for validation. In NMG-s</pubmed_abstract><journal>Cells</journal><pubmed_title>The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies.</pubmed_title><pmcid>PMC9688080</pmcid><funding_grant_id>FKZ 031 A 534A</funding_grant_id><pubmed_authors>Gerlach M</pubmed_authors><pubmed_authors>Marcus K</pubmed_authors><pubmed_authors>Eggers B</pubmed_authors><pubmed_authors>Barkovits K</pubmed_authors><pubmed_authors>Eisenacher M</pubmed_authors><pubmed_authors>Wulf M</pubmed_authors><pubmed_authors>Riederer P</pubmed_authors><pubmed_authors>Schork K</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies.</name><description>Neuromelanin granules (NMGs) are organelle-like structures present in the human &lt;i>substantia nigra pars compacta&lt;/i>. In addition to neuromelanin, NMGs contain proteins, lipids and metals. As NMG-containing dopaminergic neurons are preferentially lost in Parkinson's disease and dementia with Lewy bodies (DLB), it is assumed that NMGs may play a role in neurodegenerative processes. Until now, this role is not completely understood and needs further investigation. We therefore set up an exploratory proteomic study to identify differences in the proteomic profile of NMGs from DLB patients (n = 5) compared to healthy controls (CTRL, n = 5). We applied a laser microdissection and mass-spectrometry-based approach, in which we used targeted mass spectrometric experiments for validation. In NMG-s</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-13T14:24:25.831Z</modification><creation>2025-04-06T09:24:58.391Z</creation></dates><accession>S-EPMC9688080</accession><cross_references><pubmed>36428966</pubmed><doi>10.3390/cells11223538</doi></cross_references></HashMap>